Pericardial EffusionInflammatory Response After SurgeryPostoperative ComplicationsProcedural Sedation and AnalgesiaVideo Assisted Thoracic Surgery (VATS)Non-intubated Anesthesia
Investigational drug(s) / intervention(s)
Systemic opioid-based analgesia during NIVATSThoracic regional analgesia during NIVATS
Systemic opioid-based analgesia during NIVATS: Procedural sedation with systemic opioid analgesia, administered as part of routine clinical care. No intervention was assigned by the investigators.
Thoracic regional analgesia during NIVATS: Procedural sedation combined with paravertebral block, erector spinae plane block, or serratus anterior/intercostal plane block, administered as part of routine clinical care. No intervention was assigned by the investigators.
Study summary
Non-intubated video-assisted thoracoscopic surgery (NIVATS) is performed under spontaneous ventilation and avoids tracheal intubation and one-lung mechanical ventilation. It is increasingly used for the surgical management of pericardial effusion, where a pericardial window is created thoracoscopically. Because NIVATS avoids airway instrumentation and positive-pressure ventilation, it has been proposed to blunt the perioperative inflammatory and stress response and to support enhanced recovery after surgery targets. Within NIVATS, anaesthetic management is not uniform. In routine institutional practice, some patients are managed with procedural sedation plus systemic opioid analgesia, while others receive procedural sedation plus a thoracic regional analgesia technique. Whether this difference in analgesic strategy translates into a measurable difference in the systemic inflammatory response or in early recovery outcomes has not been established. This single-centre retrospective cohort study will review the records of adult patients who underwent NIVATS pericardial window creation for pericardial effusion at a tertiary hospital.
Eligibility
Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria:
* Adults aged 18 to 80 years
* Underwent non-intubated video-assisted thoracoscopic surgery with spontaneous ventilation for creation of a pericardial window for pericardial effusion at the study centre
* American Society of Anesthesiologists (ASA) physical status I to IV
* Available preoperative complete blood count within 24 hours before surgery and routine morning complete blood count on postoperative day 1
* Anaesthesia management module classifiable as Group A or Group B from the perioperative records
Exclusion Criteria:
* Age under 18 years or over 80 years
* Pregnancy
* Documented poor general condition or haemodynamic instability before surgery
* Requirement for inotropic or vasopressor support before surgery
* Intensive care unit stay exceeding 24 hours before surgery
* Missing preoperative or postoperative day 1 complete blood count
* Haematological malignancy, active systemic infection, or ongoing corticosteroid or immunosuppressive therapy at the time of surgery
* Anaesthesia management not classifiable into either predefined module
Primary outcome measure(s)
Change in neutrophil-to-lymphocyte ratio (delta NLR) — From within 24 hours before surgery to the morning of postoperative day 1 (06:00-10:00) NLR is calculated from the routine complete blood count as the absolute neutrophil count divided by the absolute lymphocyte count (dimensionless ratio). Delta NLR is calculated for each patient as postoperative NLR minus preoperative NLR. The preoperative value is taken from the complete blood count closest to and within 24 hours before surgery. The postoperative value is taken from the routine morning complete blood count on postoperative day 1, sampled between 06:00 and 10:00. A larger positive value indicates a greater postoperative inflammatory response. Delta NLR will be compared between the two anaesthesia management groups.
Trial sites (1)
Facility
City
Region
Status
Kosuyolu Heart Training and Research Hospital
Istanbul
Kartal
More Koşuyolu Kartal Heart Training and Research Hospital trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.